Buckingham Capital Management, Inc. Astrazeneca PLC Transaction History

Buckingham Capital Management, Inc.

$863 Million
Q3 2024

A detailed history of Buckingham Capital Management, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Buckingham Capital Management, Inc. holds 195,004 shares of AZN stock, worth $12.6 Million. This represents 1.76% of its overall portfolio holdings.

Number of Shares

195,004

Previous 205,137 4.94%

Holding current value

$12.6 Million

Previous $16 Million 5.03%

% of portfolio

1.76%

Previous 1.94%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$76.67 - $87.62 $776,897 - $887,853	-10,133 Reduced 4.94%	195,004 $15.2 Million
Q2 2024 Jul 15, 2024	SELL	$66.81 - $80.83 $206,108 - $249,360	-3,085 Reduced 1.48%	205,137 $16 Million
Q1 2024 Apr 10, 2024	BUY	$61.03 - $69.57 $409,450 - $466,745	6,709 Added 3.33%	208,222 $14.1 Million
Q4 2023 Feb 07, 2024	BUY	$61.89 - $69.28 $117,962 - $132,047	1,906 Added 0.95%	201,513 $13.6 Million
Q3 2023 Oct 13, 2023	BUY	$64.85 - $71.7 $214,783 - $237,470	3,312 Added 1.69%	199,607 $13.5 Million
Q2 2023 Jul 11, 2023	SELL	$69.91 - $75.81 $365,769 - $396,637	-5,232 Reduced 2.6%	196,295 $14 Million
Q1 2023 Apr 11, 2023	BUY	$63.15 - $71.6 $172,273 - $195,324	2,728 Added 1.37%	201,527 $14 Million
Q4 2022 Jan 24, 2023	BUY	$54.21 - $70.44 $119,966 - $155,883	2,213 Added 1.13%	198,799 $0
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $342,880 - $877,895	6,467 Added 3.4%	196,586 $10.8 Million
Q2 2022 Aug 05, 2022	SELL	$59.26 - $71.14 $275,914 - $331,227	-4,656 Reduced 2.39%	190,119 $12.6 Million
Q1 2022 May 06, 2022	BUY	$55.72 - $67.12 $118,739 - $143,032	2,131 Added 1.11%	194,775 $12.9 Million
Q4 2021 Feb 07, 2022	BUY	$54.02 - $63.83 $221,806 - $262,085	4,106 Added 2.18%	192,644 $11.2 Million
Q3 2021 Nov 08, 2021	BUY	$55.56 - $60.79 $320,247 - $350,393	5,764 Added 3.15%	188,538 $11.3 Million
Q2 2021 Jul 27, 2021	BUY	$48.42 - $60.18 $228,687 - $284,230	4,723 Added 2.65%	182,774 $10.9 Million
Q1 2021 May 04, 2021	BUY	$47.16 - $54.44 $91,584 - $105,722	1,942 Added 1.1%	178,051 $8.85 Million
Q4 2020 Feb 04, 2021	BUY	$48.52 - $58.02 $171,275 - $204,810	3,530 Added 2.05%	176,109 $8.8 Million
Q3 2020 Nov 02, 2020	BUY	$53.07 - $61.1 $416,546 - $479,573	7,849 Added 4.76%	172,579 $9.46 Million
Q2 2020 Jul 20, 2020	BUY	$43.1 - $55.31 $827,563 - $1.06 Million	19,201 Added 13.19%	164,730 $8.71 Million
Q1 2020 May 06, 2020	SELL	$37.79 - $51.33 $695,978 - $945,344	-18,417 Reduced 11.23%	145,529 $6.5 Million
Q4 2019 Feb 13, 2020	BUY	$42.46 - $50.46 $864,528 - $1.03 Million	20,361 Added 14.18%	163,946 $8.17 Million
Q3 2019 Nov 12, 2019	BUY	$40.12 - $45.47 $1.56 Million - $1.77 Million	38,852 Added 37.1%	143,585 $6.4 Million
Q2 2019 Aug 09, 2019	BUY	$37.28 - $41.68 $1.74 Million - $1.94 Million	46,638 Added 80.28%	104,733 $4.32 Million
Q1 2019 May 07, 2019	BUY	$35.49 - $43.02 $1.09 Million - $1.33 Million	30,843 Added 113.18%	58,095 $2.35 Million
Q4 2018 Feb 04, 2019	SELL	$36.86 - $41.49 $921 - $1,037	-25 Reduced 0.09%	27,252 $1.04 Million
Q3 2018 Nov 20, 2018	BUY	$34.76 - $39.72 $10,949 - $12,511	315 Added 1.17%	27,277 $1.08 Million
Q2 2018 Aug 10, 2018	BUY	$34.55 - $37.05 $39,525 - $42,385	1,144 Added 4.43%	26,962 $947,000
Q1 2018 May 11, 2018	BUY	$32.97 - $36.63 $17,507 - $19,450	531 Added 2.1%	25,818 $903,000
Q4 2017 Feb 13, 2018	BUY	$32.09 - $34.78 $33,887 - $36,727	1,056 Added 4.36%	25,287 $877,000
Q3 2017 Nov 07, 2017	BUY	$28.96 - $34.0 $29,046 - $34,102	1,003 Added 4.32%	24,231 $821,000
Q2 2017 Aug 10, 2017	BUY	N/A	23,228	23,228 $792,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckingham Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Buckingham Capital Management, Inc. with notifications on news.

Account

Buckingham Capital Management, Inc. Astrazeneca PLC Transaction History